R. Corre

10.1k citations
89 papers · 8.0k · 3 hit papers · h-index 19

Impact in

    • Lung Cancer Treatments and Mutations
    • Occupational and environmental lung diseases
    • Lung Cancer Diagnosis and Treatment
    • Pleural and Pulmonary Diseases
  • Oncology top 1%
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Lung Cancer Treatments and Mutations 28
    • Lung Cancer Diagnosis and Treatment 11
    • Occupational and environmental lung diseases 5
    • Cancer Immunotherapy and Biomarkers 22
    • Lung Cancer Research Studies 12
    • Colorectal Cancer Treatments and Studies 4

R. Corre

79 papers receiving 7.8k citations

R. Corre's Hit Papers

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial 2019 · 364 citations
3640+4+9Years since publication10002.0k3.0k4.0k

Peers

R. Corre
Comparison fields: 5 of 106
  • Pulmonary and Respiratory Medicine 5.6k
  • Oncology 3.0k
  • Geriatrics and Gerontology 245
  • Cancer Research 1.0k
  • Genetics 477
Replace Claus‐Henning Köhne with:
Claus‐Henning Köhne Germany
H. Léna France
Éric Dansin France
Nathalie Baize France
Delphine Borchiellini France
Ciara Marie Kelly United States
Rodolfo F. Perini United States
Ramón Palmero Spain
Adam Płużański Poland
Daniel Waterkamp United States
R. Corre relative to Claus‐Henning Köhne Germany Claus‐Henning Köhne's profile →
Citations per field
00.5×2×4×6.0×
Claus‐Henning Köhne · 1×
Citations per year

Countries citing papers authored by R. Corre

Since Specialization
Citations

This map shows the geographic impact of R. Corre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Corre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Corre more than expected).

Fields of papers citing papers by R. Corre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Corre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Corre. The network helps show where R. Corre may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Corre, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Corre Line = papers co-authored together R. Corre links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 89 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Hit paper breakdown →
20124725
2
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
Hit paper breakdown →
2015758
3
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial
Hit paper breakdown →
2019364
4 2016297
5 2012295
6 2015222
7 2019180
8 2007147
9 2014138
10 2019102
11 201853
12 201952
13 201449
14 202049
15 202245
16 201029
17 201628
18 201121
19 201820
20 201219

About R. Corre

R. Corre is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Geriatrics and Gerontology, Genetics and Epidemiology, having authored 89 papers that have together received 8.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (28 papers), Cancer Immunotherapy and Biomarkers (22 papers), Lung Cancer Research Studies (12 papers), Lung Cancer Diagnosis and Treatment (11 papers), Frailty in Older Adults (7 papers), Occupational and environmental lung diseases (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (5.6k citations), Oncology (3.0k citations), Geriatrics and Gerontology (245 citations), Cancer Research (1.0k citations) and Genetics (477 citations). R. Corre has collaborated with scholars based in France, United States and Spain. Frequent co-authors include CHRISTOS CHOUAID, Éric Marchand, Jean-François Cordier, Henri Plauchu, Thierry Chinet, Vincent Cottin, Martine Reynaud‐Gaubert, A. Lavolé, Alain Vergnenégre and Jean‐Baptiste Assié. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Lung Cancer, Targeted Oncology and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact